Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases.

Kosloski LM, Ha DM, Hutter JA, Stone DK, Pichler MR, Reynolds AD, Gendelman HE, Mosley RL.

J Neurochem. 2010 Sep 1;114(5):1261-76. doi: 10.1111/j.1471-4159.2010.06834.x. Epub 2010 May 26. Review.

2.

Immunization strategies for Parkinson's disease.

Ha D, Stone DK, Mosley RL, Gendelman HE.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S218-21. doi: 10.1016/S1353-8020(11)70067-0. Review.

PMID:
22166440
3.

Pathways towards an effective immunotherapy for Parkinson's disease.

Hutter-Saunders JA, Mosley RL, Gendelman HE.

Expert Rev Neurother. 2011 Dec;11(12):1703-15. doi: 10.1586/ern.11.163. Review.

4.

Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders.

Mosley RL, Gendelman HE.

Exp Neurol. 2010 Mar;222(1):1-5. doi: 10.1016/j.expneurol.2009.12.018. Epub 2010 Jan 4.

5.

The innate and adaptive immunological aspects in neurodegenerative diseases.

Rodrigues MC, Sanberg PR, Cruz LE, Garbuzova-Davis S.

J Neuroimmunol. 2014 Apr 15;269(1-2):1-8. doi: 10.1016/j.jneuroim.2013.09.020. Epub 2013 Oct 5. Review.

PMID:
24161471
6.

A common vaccine for fighting neurodegenerative disorders: recharging immunity for homeostasis.

Schwartz M, Kipnis J.

Trends Pharmacol Sci. 2004 Aug;25(8):407-12. Review.

PMID:
15276709
7.

CD 4+ T cells in the pathobiology of neurodegenerative disorders.

Huang X, Reynolds AD, Mosley RL, Gendelman HE.

J Neuroimmunol. 2009 Jun 25;211(1-2):3-15. doi: 10.1016/j.jneuroim.2009.04.006. Epub 2009 May 12. Review.

8.

Adaptive Immunity in Neurodegenerative and Neuropsychological Disorders.

Mosley RL.

J Neuroimmune Pharmacol. 2015 Dec;10(4):522-7. doi: 10.1007/s11481-015-9640-y. Epub 2015 Oct 26. Review.

PMID:
26496777
9.

A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders.

Gendelman HE, Mosley RL.

J Neuroimmune Pharmacol. 2015 Dec;10(4):645-50. doi: 10.1007/s11481-015-9639-4. Epub 2015 Oct 31. Review.

10.

Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.

Anderson KM, Olson KE, Estes KA, Flanagan K, Gendelman HE, Mosley RL.

Transl Neurodegener. 2014 Nov 13;3(1):25. doi: 10.1186/2047-9158-3-25. eCollection 2014. Review.

11.

Stress proteins and glial functions: possible therapeutic targets for neurodegenerative disorders.

Kitamura Y, Nomura Y.

Pharmacol Ther. 2003 Jan;97(1):35-53. Review.

PMID:
12493534
12.

A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders.

Kountouras J, Deretzi G, Gavalas E, Zavos C, Polyzos SA, Kazakos E, Giartza-Taxidou E, Vardaka E, Kountouras C, Katsinelos P, Boziki M, Giouleme O.

Med Hypotheses. 2014 Mar;82(3):368-73. doi: 10.1016/j.mehy.2013.12.025. Epub 2014 Jan 14. Review.

PMID:
24472867
13.

Inflammation in neurodegenerative diseases.

Amor S, Puentes F, Baker D, van der Valk P.

Immunology. 2010 Feb;129(2):154-69. doi: 10.1111/j.1365-2567.2009.03225.x. Review.

14.

To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?

Marchetti B, Abbracchio MP.

Trends Pharmacol Sci. 2005 Oct;26(10):517-25. Review.

PMID:
16126283
15.

New therapeutic strategy for Parkinson's and Alzheimer's disease.

Esposito E, Cuzzocrea S.

Curr Med Chem. 2010;17(25):2764-74. Review.

PMID:
20586718
16.

Humoral response against glial derived antigens in Parkinson's disease.

Papuć E, Kurzepa J, Kurys-Denis E, Grabarska A, Krupski W, Rejdak K.

Neurosci Lett. 2014 Apr 30;566:77-81. doi: 10.1016/j.neulet.2014.02.043. Epub 2014 Mar 1.

PMID:
24594199
17.

Oxidative stress and the pathogenesis of neurodegenerative disorders.

Reynolds A, Laurie C, Mosley RL, Gendelman HE.

Int Rev Neurobiol. 2007;82:297-325. Review.

PMID:
17678968
18.

Complement in the brain.

Veerhuis R, Nielsen HM, Tenner AJ.

Mol Immunol. 2011 Aug;48(14):1592-603. doi: 10.1016/j.molimm.2011.04.003. Epub 2011 May 4. Review.

19.

Neuroglial roots of neurodegenerative diseases?

Rodríguez JJ, Verkhratsky A.

Mol Neurobiol. 2011 Apr;43(2):87-96. doi: 10.1007/s12035-010-8157-x. Epub 2010 Dec 15. Review.

PMID:
21161612
20.

LXR agonists: new potential therapeutic drug for neurodegenerative diseases.

Xu P, Li D, Tang X, Bao X, Huang J, Tang Y, Yang Y, Xu H, Fan X.

Mol Neurobiol. 2013 Dec;48(3):715-28. doi: 10.1007/s12035-013-8461-3. Epub 2013 Apr 27. Review.

PMID:
23625315

Supplemental Content

Support Center